SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $4,000 | -94.2% | 38,418 | -5.5% | 0.00% | – |
Q3 2018 | $69,000 | -2.8% | 40,634 | 0.0% | 0.00% | – |
Q2 2018 | $71,000 | -15.5% | 40,634 | -12.0% | 0.00% | – |
Q1 2018 | $84,000 | -39.6% | 46,187 | -25.3% | 0.00% | – |
Q4 2017 | $139,000 | -21.0% | 61,803 | +0.2% | 0.00% | – |
Q3 2017 | $176,000 | -29.3% | 61,701 | +9.5% | 0.00% | – |
Q2 2017 | $249,000 | +7.8% | 56,358 | +13.9% | 0.00% | – |
Q1 2017 | $231,000 | -13.2% | 49,476 | +12.2% | 0.00% | – |
Q4 2016 | $266,000 | +91.4% | 44,109 | +68.1% | 0.00% | – |
Q3 2016 | $139,000 | +27.5% | 26,236 | -10.6% | 0.00% | – |
Q2 2016 | $109,000 | +118.0% | 29,343 | +60.0% | 0.00% | – |
Q1 2016 | $50,000 | -51.9% | 18,342 | 0.0% | 0.00% | – |
Q4 2015 | $104,000 | +4.0% | 18,342 | 0.0% | 0.00% | – |
Q3 2015 | $100,000 | -32.4% | 18,342 | 0.0% | 0.00% | – |
Q2 2015 | $148,000 | +82.7% | 18,342 | 0.0% | 0.00% | – |
Q1 2015 | $81,000 | +44.6% | 18,342 | 0.0% | 0.00% | – |
Q4 2014 | $56,000 | +7.7% | 18,342 | 0.0% | 0.00% | – |
Q3 2014 | $52,000 | – | 18,342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |